Christina Lynn Marcaccio, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Endovascular Procedures | 28 | 2024 | 2183 | 3.420 |
Why?
|
Blood Vessel Prosthesis Implantation | 20 | 2024 | 1428 | 3.100 |
Why?
|
Aortic Aneurysm, Abdominal | 19 | 2024 | 1228 | 2.750 |
Why?
|
Carotid Stenosis | 8 | 2023 | 860 | 2.440 |
Why?
|
Vascular System Injuries | 7 | 2024 | 246 | 1.470 |
Why?
|
Thoracic Injuries | 7 | 2024 | 288 | 1.420 |
Why?
|
Wounds, Nonpenetrating | 8 | 2024 | 807 | 1.320 |
Why?
|
Peripheral Arterial Disease | 5 | 2024 | 1273 | 1.040 |
Why?
|
Stroke | 10 | 2023 | 9758 | 0.950 |
Why?
|
Blood Vessel Prosthesis | 6 | 2024 | 951 | 0.930 |
Why?
|
Endarterectomy, Carotid | 3 | 2023 | 555 | 0.860 |
Why?
|
Stents | 11 | 2024 | 3179 | 0.820 |
Why?
|
Aortic Rupture | 5 | 2022 | 319 | 0.790 |
Why?
|
Femoral Artery | 4 | 2023 | 826 | 0.780 |
Why?
|
Aorta, Thoracic | 7 | 2024 | 1096 | 0.700 |
Why?
|
Catheterization, Peripheral | 1 | 2021 | 343 | 0.590 |
Why?
|
Aneurysm, Ruptured | 1 | 2022 | 464 | 0.550 |
Why?
|
Treatment Outcome | 38 | 2024 | 64685 | 0.550 |
Why?
|
Aortic Aneurysm | 1 | 2021 | 648 | 0.540 |
Why?
|
Thromboembolism | 1 | 2022 | 995 | 0.530 |
Why?
|
Aortic Aneurysm, Thoracic | 4 | 2023 | 696 | 0.530 |
Why?
|
Platelet Aggregation Inhibitors | 3 | 2022 | 2751 | 0.510 |
Why?
|
Risk Factors | 36 | 2024 | 74213 | 0.500 |
Why?
|
Spinal Cord Ischemia | 2 | 2023 | 94 | 0.390 |
Why?
|
Carotid Arteries | 4 | 2023 | 941 | 0.370 |
Why?
|
Risk Assessment | 15 | 2024 | 23996 | 0.360 |
Why?
|
Vascular Surgical Procedures | 4 | 2024 | 1489 | 0.360 |
Why?
|
Retrospective Studies | 33 | 2024 | 80647 | 0.360 |
Why?
|
Olfactory Bulb | 3 | 2017 | 198 | 0.340 |
Why?
|
Eligibility Determination | 2 | 2021 | 421 | 0.290 |
Why?
|
Olfactory Receptor Neurons | 3 | 2017 | 96 | 0.280 |
Why?
|
Ischemia | 4 | 2024 | 1884 | 0.280 |
Why?
|
Hospital Mortality | 4 | 2023 | 5293 | 0.280 |
Why?
|
Aspirin | 3 | 2022 | 3133 | 0.260 |
Why?
|
Prosthesis Design | 2 | 2024 | 2115 | 0.250 |
Why?
|
Time Factors | 15 | 2024 | 39969 | 0.220 |
Why?
|
Lower Extremity | 2 | 2022 | 1202 | 0.210 |
Why?
|
Postoperative Complications | 10 | 2024 | 15633 | 0.200 |
Why?
|
Protamines | 1 | 2021 | 112 | 0.190 |
Why?
|
Iliac Aneurysm | 1 | 2020 | 37 | 0.180 |
Why?
|
Databases, Factual | 5 | 2024 | 7968 | 0.180 |
Why?
|
Humans | 43 | 2024 | 761596 | 0.170 |
Why?
|
Medicare | 6 | 2023 | 6770 | 0.170 |
Why?
|
United States | 12 | 2024 | 72340 | 0.170 |
Why?
|
Embolism | 1 | 2023 | 399 | 0.170 |
Why?
|
Abdominal Injuries | 1 | 2022 | 360 | 0.160 |
Why?
|
Constriction, Pathologic | 1 | 2023 | 1096 | 0.160 |
Why?
|
Humanism | 1 | 2019 | 86 | 0.160 |
Why?
|
Habits | 1 | 2019 | 147 | 0.160 |
Why?
|
Aged | 17 | 2024 | 169310 | 0.140 |
Why?
|
Upper Extremity | 1 | 2022 | 658 | 0.140 |
Why?
|
Aortic Diseases | 1 | 2023 | 735 | 0.140 |
Why?
|
Axons | 2 | 2017 | 1674 | 0.140 |
Why?
|
Ischemic Attack, Transient | 1 | 2022 | 882 | 0.140 |
Why?
|
Carotid Artery Diseases | 1 | 2023 | 877 | 0.130 |
Why?
|
Neuropilin-2 | 1 | 2016 | 55 | 0.130 |
Why?
|
Chi-Square Distribution | 2 | 2022 | 3415 | 0.130 |
Why?
|
Neuropilin-1 | 1 | 2016 | 90 | 0.130 |
Why?
|
Angiography | 1 | 2020 | 1595 | 0.120 |
Why?
|
Minority Groups | 1 | 2022 | 1203 | 0.120 |
Why?
|
Olfactory Pathways | 1 | 2016 | 132 | 0.120 |
Why?
|
Injury Severity Score | 1 | 2018 | 1045 | 0.110 |
Why?
|
Practice Guidelines as Topic | 2 | 2021 | 7391 | 0.110 |
Why?
|
Reoperation | 1 | 2024 | 4303 | 0.110 |
Why?
|
Nerve Growth Factors | 2 | 2016 | 564 | 0.110 |
Why?
|
Sex Factors | 3 | 2021 | 10554 | 0.110 |
Why?
|
Fibrinolytic Agents | 1 | 2022 | 2084 | 0.100 |
Why?
|
Chronic Disease | 2 | 2024 | 9319 | 0.100 |
Why?
|
Neurogenesis | 1 | 2017 | 863 | 0.090 |
Why?
|
Faculty, Medical | 1 | 2019 | 1204 | 0.090 |
Why?
|
Female | 17 | 2024 | 392705 | 0.090 |
Why?
|
Hemorrhage | 1 | 2022 | 3424 | 0.090 |
Why?
|
Zebrafish | 3 | 2017 | 3008 | 0.080 |
Why?
|
Zebrafish Proteins | 2 | 2016 | 1015 | 0.080 |
Why?
|
Anticoagulants | 2 | 2022 | 4812 | 0.080 |
Why?
|
Venous Thromboembolism | 1 | 2022 | 1866 | 0.080 |
Why?
|
Male | 16 | 2024 | 360846 | 0.080 |
Why?
|
Health Status Disparities | 1 | 2021 | 1853 | 0.080 |
Why?
|
Hospitals | 1 | 2022 | 3883 | 0.080 |
Why?
|
Limb Salvage | 2 | 2022 | 481 | 0.080 |
Why?
|
Clinical Competence | 1 | 2024 | 4793 | 0.080 |
Why?
|
Aged, 80 and over | 6 | 2024 | 58984 | 0.070 |
Why?
|
Age Factors | 2 | 2021 | 18399 | 0.070 |
Why?
|
Receptors, Cell Surface | 2 | 2016 | 2822 | 0.070 |
Why?
|
Tumor Suppressor Proteins | 2 | 2016 | 2805 | 0.060 |
Why?
|
Incidence | 2 | 2021 | 21355 | 0.060 |
Why?
|
Odds Ratio | 1 | 2018 | 9647 | 0.060 |
Why?
|
Aorta | 2 | 2023 | 2041 | 0.060 |
Why?
|
Attitude of Health Personnel | 1 | 2019 | 3889 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2021 | 3358 | 0.060 |
Why?
|
Multivariate Analysis | 1 | 2018 | 12059 | 0.060 |
Why?
|
Prevalence | 1 | 2021 | 15733 | 0.060 |
Why?
|
Logistic Models | 1 | 2018 | 13255 | 0.050 |
Why?
|
Endoleak | 1 | 2022 | 111 | 0.050 |
Why?
|
Retroperitoneal Space | 1 | 2022 | 170 | 0.050 |
Why?
|
Middle Aged | 6 | 2024 | 220921 | 0.050 |
Why?
|
Predictive Value of Tests | 3 | 2021 | 15266 | 0.040 |
Why?
|
Intermittent Claudication | 1 | 2023 | 304 | 0.040 |
Why?
|
Animals, Genetically Modified | 2 | 2017 | 1561 | 0.040 |
Why?
|
North America | 1 | 2021 | 1276 | 0.040 |
Why?
|
Aorta, Abdominal | 1 | 2020 | 625 | 0.040 |
Why?
|
Treatment Failure | 1 | 2024 | 2643 | 0.040 |
Why?
|
Arteries | 1 | 2022 | 1123 | 0.040 |
Why?
|
Sex Distribution | 1 | 2021 | 2280 | 0.030 |
Why?
|
Heparin | 1 | 2023 | 1634 | 0.030 |
Why?
|
Semaphorins | 1 | 2016 | 96 | 0.030 |
Why?
|
Propensity Score | 1 | 2023 | 1913 | 0.030 |
Why?
|
Patient Admission | 1 | 2021 | 1367 | 0.030 |
Why?
|
Workplace | 1 | 2019 | 863 | 0.030 |
Why?
|
Signal Transduction | 2 | 2016 | 23447 | 0.030 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2016 | 3612 | 0.030 |
Why?
|
Olfactory Marker Protein | 1 | 2012 | 12 | 0.030 |
Why?
|
Internal Medicine | 1 | 2019 | 1051 | 0.020 |
Why?
|
Receptors, Odorant | 1 | 2012 | 67 | 0.020 |
Why?
|
TRPC Cation Channels | 1 | 2012 | 111 | 0.020 |
Why?
|
Cues | 1 | 2016 | 875 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39106 | 0.020 |
Why?
|
Patient Discharge | 1 | 2023 | 3443 | 0.020 |
Why?
|
Qualitative Research | 1 | 2019 | 3025 | 0.020 |
Why?
|
Pain | 1 | 2023 | 5073 | 0.020 |
Why?
|
Physician-Patient Relations | 1 | 2019 | 3251 | 0.020 |
Why?
|
Registries | 1 | 2021 | 8225 | 0.020 |
Why?
|
Molecular Imaging | 1 | 2012 | 815 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15843 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2020 | 20100 | 0.010 |
Why?
|
Animals | 3 | 2017 | 168475 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2016 | 9610 | 0.010 |
Why?
|
Adult | 2 | 2024 | 221210 | 0.010 |
Why?
|
Transcription Factors | 1 | 2016 | 12130 | 0.010 |
Why?
|
Mutation | 1 | 2012 | 30053 | 0.000 |
Why?
|